{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:29:38Z","timestamp":1791948578168,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K07CA222343"],"award-info":[{"award-number":["K07CA222343"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K12HD052023"],"award-info":[{"award-number":["K12HD052023"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["T32HD055163"],"award-info":[{"award-number":["T32HD055163"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s13187-020-01823-0","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:03:27Z","timestamp":1594253007000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Knowledge, Attitudes, Willingness to Pay, and Patient Preferences About Genetic Testing and Subsequent Risk Management for Cancer Prevention"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3729-2724","authenticated-orcid":false,"given":"Fangjian","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Hirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie E.","family":"Cofie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbey B.","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"issue":"1","key":"1823_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7\u201330","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1823_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/PPO.0b013e31823e5387","volume":"17","author":"MM Pomerantz","year":"2011","unstructured":"Pomerantz MM, Freedman ML (2011) The genetics of cancer risk. Cancer J 17(6):416\u2013422","journal-title":"Cancer J"},{"issue":"2","key":"1823_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343(2):78\u201385","journal-title":"N Engl J Med"},{"issue":"5","key":"1823_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3322\/caac.20128","volume":"61","author":"JN Weitzel","year":"2011","unstructured":"Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K (2011) Genetics, genomics, and cancer risk assessment: state of the art and future directions in the era of personalized medicine. CA Cancer J Clin 61(5):327\u2013359","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1823_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMcp071286","volume":"357","author":"M Robson","year":"2007","unstructured":"Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357(2):154\u2013162","journal-title":"N Engl J Med"},{"issue":"10","key":"1823_CR6","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1002\/cncr.23903","volume":"113","author":"GF Schwartz","year":"2008","unstructured":"Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ, and the Consensus Conference Committee (2008) Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Cancer. 113(10):2627\u20132637","journal-title":"Cancer."},{"issue":"4","key":"1823_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/M13-1684","volume":"160","author":"HD Nelson","year":"2014","unstructured":"Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160(4):255\u2013266","journal-title":"Ann Intern Med"},{"issue":"7","key":"1823_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/jmg.2007.056556","volume":"45","author":"AC Antoniou","year":"2008","unstructured":"Antoniou AC, Hardy R, Walker L, Evans DG, Shenton A, Eeles R, Shanley S, Pichert G, Izatt L, Rose S, Douglas F, Eccles D, Morrison PJ, Scott J, Zimmern RL, Easton DF, Pharoah PDP (2008) Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet 45(7):425\u2013431","journal-title":"J Med Genet"},{"issue":"5","key":"1823_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","volume":"143","author":"HD Nelson","year":"2005","unstructured":"Nelson HD, Huffman LH, Fu R, Harris EL (2005) Force USPST. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 143(5):362\u2013379","journal-title":"Ann Intern Med"},{"issue":"3","key":"1823_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1056\/NEJM199601183340302","volume":"334","author":"MG FitzGerald","year":"1996","unstructured":"FitzGerald MG, MacDonald DJ, Krainer M et al (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334(3):143\u2013149","journal-title":"N Engl J Med"},{"issue":"1","key":"1823_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/jnci\/dju420","volume":"107","author":"E Levy-Lahad","year":"2015","unstructured":"Levy-Lahad E, Lahad A, King MC (2015) Precision medicine meets public health: population screening for BRCA1 and BRCA2. J Natl Cancer Inst 107(1):420","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1823_CR12","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.3747\/co.22.2527","volume":"22","author":"KA Metcalfe","year":"2015","unstructured":"Metcalfe KA, Eisen A, Lerner-Ellis J, Narod SA (2015) Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? Curr Oncol 22(4):e233\u2013e236","journal-title":"Curr Oncol"},{"key":"1823_CR13","doi-asserted-by":"crossref","unstructured":"Kemp Z (2020) Breast Unit RMNHSFT, London, United Kingdom, Cancer Genetics Unit RMNHSFT, London, United Kingdom, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Network Open 2(5)","DOI":"10.1001\/jamanetworkopen.2019.4428"},{"issue":"21","key":"1823_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, Friedlander M, Fox S, Bowtell D, Mitchell G (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30(21):2654\u20132663","journal-title":"J Clin Oncol"},{"key":"1823_CR15","unstructured":"Color Test $249. https:\/\/getcolor.com\/kit\/how-it-works. Accessed Sept 9, 2016"},{"issue":"6","key":"1823_CR16","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1245\/s10434-012-2257-y","volume":"19","author":"B Drohan","year":"2012","unstructured":"Drohan B, Roche CA, Cusack JC, Hughes KS (2012) Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers. Ann Surg Oncol 19(6):1732\u20131737","journal-title":"Ann Surg Oncol"},{"key":"1823_CR17","unstructured":"American Cancer Society. Breast Cancer Facts & Figures 2015\u20132016. Atlanta: American Cancer Society, Inc. 2015. http:\/\/www.cancer.org\/acs\/groups\/content\/@research\/documents\/document\/acspc-046381.pdf. Accessed on Jun 30, 2016. In"},{"issue":"23","key":"1823_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98(23):1694\u20131706","journal-title":"J Natl Cancer Inst"},{"key":"1823_CR19","unstructured":"National Center for Health Statistics. Survey Description, National Health Interview Survey, 2013. Hyattsville, Maryland. 2014"},{"issue":"6","key":"1823_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s10897-014-9724-5","volume":"23","author":"JM Matro","year":"2014","unstructured":"Matro JM, Ruth KJ, Wong YN, McCully KC, Rybak CM, Meropol NJ, Hall MJ (2014) Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing. J Genet Couns 23(6):1002\u20131011","journal-title":"J Genet Couns"},{"issue":"5","key":"1823_CR21","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/01.GIM.0000162876.65555.AB","volume":"7","author":"M van den Berg","year":"2005","unstructured":"van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G (2005) Are pregnant women making informed choices about prenatal screening? Genet Med. 7(5):332\u2013338","journal-title":"Genet Med."},{"issue":"2","key":"1823_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/pd.2205","volume":"29","author":"L Kooij","year":"2009","unstructured":"Kooij L, Tymstra T, Berg P (2009) The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 29(2):164\u2013168","journal-title":"Prenat Diagn"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.socscimed.2016.04.028","volume":"159","author":"KV Galbraith","year":"2016","unstructured":"Galbraith KV, Lechuga J, Jenerette CM, Moore LA, Palmer MH, Hamilton JB (2016) Parental acceptance and uptake of the HPV vaccine among African-Americans and Latinos in the United States: a literature review. Soc Sci Med 159:116\u2013126","journal-title":"Soc Sci Med"},{"issue":"3","key":"1823_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/01.gim.0000204458.84988.f2","volume":"8","author":"GE Palomaki","year":"2006","unstructured":"Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE (2006) Screen-positive rates and agreement among six family history screening protocols for breast\/ovarian cancer in a population-based cohort of 21- to 55-year-old women. Genet Med. 8(3):161\u2013168","journal-title":"Genet Med."},{"issue":"4","key":"1823_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10689-008-9188-6","volume":"7","author":"MR McClain","year":"2008","unstructured":"McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE (2008) Screen positive rates among six family history screening protocols for breast\/ovarian cancer in four cohorts of women. Familial Cancer 7(4):341\u2013345","journal-title":"Familial Cancer"},{"key":"1823_CR26","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast and Ovarian. Version 1.2018. Fort Washington, PA: National Comprehensive Cancer Network, 2017. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed Oct 5, 2017. In"},{"issue":"1","key":"1823_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/gim.2014.147","volume":"17","author":"H Hampel","year":"2015","unstructured":"Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL (2015) Guideline development group AeCoMGaGPPaGCaNSoGCPGC. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 17(1):70\u201387","journal-title":"Genet Med"},{"key":"1823_CR28","doi-asserted-by":"crossref","unstructured":"Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer. 2000;83(10):1301\u20131308","DOI":"10.1054\/bjoc.2000.1407"},{"issue":"39","key":"1823_CR29","doi-asserted-by":"publisher","first-page":"14205","DOI":"10.1073\/pnas.1415979111","volume":"111","author":"E Gabai-Kapara","year":"2014","unstructured":"Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, Beeri R, Gal M, Grinshpun-Cohen J, Djemal K, Mandell JB, Lee MK, Beller U, Catane R, King MC, Levy-Lahad E (2014) Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A 111(39):14205\u201314210","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1823_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12889-017-4375-8","volume":"17","author":"KEJ Hann","year":"2017","unstructured":"Hann KEJ, Freeman M, Fraser L et al (2017) Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review. BMC Public Health 17(1):503","journal-title":"BMC Public Health"},{"issue":"6","key":"1823_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1006\/pmed.2001.0920","volume":"33","author":"AY Kinney","year":"2001","unstructured":"Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL (2001) Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med 33(6):543\u2013551","journal-title":"Prev Med"},{"issue":"2","key":"1823_CR32","first-page":"78","volume":"9","author":"P Sankar","year":"2006","unstructured":"Sankar P, Wolpe PR, Jones NL, Cho M (2006) How do women decide? Accepting or declining BRCA1\/2 testing in a nationwide clinical sample in the United States. Community Genet 9(2):78\u201386","journal-title":"Community Genet"},{"issue":"3","key":"1823_CR33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1055-9965.361.13.3","volume":"13","author":"N Peters","year":"2004","unstructured":"Peters N, Rose A, Armstrong K (2004) The association between race and attitudes about predictive genetic testing. Cancer Epidemiol Biomark Prev 13(3):361\u2013365","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"20","key":"1823_CR34","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1056\/NEJMp078033","volume":"356","author":"KL Hudson","year":"2007","unstructured":"Hudson KL (2007) Prohibiting genetic discrimination. N Engl J Med 356(20):2021\u20132023","journal-title":"N Engl J Med"},{"issue":"1","key":"1823_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/gte.2007.0037","volume":"12","author":"E Finlay","year":"2008","unstructured":"Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM (2008) Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1\/2 mutations. Genet Test 12(1):81\u201391","journal-title":"Genet Test"},{"issue":"2","key":"1823_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10689-004-7991-2","volume":"4","author":"K Landsbergen","year":"2005","unstructured":"Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N (2005) Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Familial Cancer 4(2):115\u2013119","journal-title":"Familial Cancer"},{"issue":"Suppl 1","key":"1823_CR37","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1093\/annonc\/mdq668","volume":"22","author":"A Surbone","year":"2011","unstructured":"Surbone A (2011) Social and ethical implications of BRCA testing. Ann Oncol 22(Suppl 1):i60\u2013i66","journal-title":"Ann Oncol"},{"issue":"2","key":"1823_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/cncr.26294","volume":"118","author":"MD Schwartz","year":"2012","unstructured":"Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L (2012) Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance. Cancer. 118(2):510\u2013517","journal-title":"Cancer."},{"issue":"2","key":"1823_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"1823_CR40","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93(21):1633\u20131637","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"1823_CR41","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1200\/JCO.2009.27.0660","volume":"28","author":"ME Robson","year":"2010","unstructured":"Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K (2010) Oncology ASoC. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 28(5):893\u2013901","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-020-01823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-020-01823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-020-01823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:30:31Z","timestamp":1723217431000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-020-01823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1007\/s13187-020-01823-0","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"9 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The Institutional Review Board at The University of Texas Medical Branch approved this study, including a waiver of written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval (Include Appropriate Approvals or Waivers)"}},{"value":"Oral consent from the participants was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Code is available upon request to the corresponding author, Dr. Fangjian Guo (faguo@utmb.edu).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability (Software Application or Custom Code)"}}]}}